NCT04666077Completed
Music Therapy Experiences in Patients With Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)
A Randomized, Blinded, Controlled Trial of Music Therapy Singing Interventions for Patients With MCI and AD
Source: ClinicalTrials.gov · Last updated 17 Dec 2025
Brief summary (registry, in English)
This study compares different music therapy (MT) experiences and their impact on memory and language in patients with Alzheimer's disease and Mild Cognitive Impairment. The 12-month study will assess the role of common experiences involving familiar music and other pleasant events (blinded control) to benefit cognition and measure the quality of life for people with Alzheimer's disease and Mild Cognitive Impairment. Following screening, all participants will meet with a licensed music therapist at the first study visit. Thereafter, each group will have an individualized schedule of follow-up telephone calls and visits. Screening for the study and participation in the study intervention can be completed in-person or from your home, if you do not live in the area.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 100 (actual)
- First submitted
- 7 Dec 2020
- Start date
- 27 Aug 2019
- Primary completion date
- 15 Jul 2025
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Diseases
- Alzheimer disease
- NCT number
- NCT04666077
What you commit to
- Study type: Interventional
- Participants enrolled: 100
- From 27 Aug 2019 to the primary completion date, 15 Jul 2025
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- A diagnosis of dementia other than probable or possible AD
- Probable AD with Down syndrome
- History of a clinically significant stroke with residual deficit
- Current evidence or history in past two years of epilepsy, focal brain lesion, head injury
- Current diagnosis for major psychiatric disorder including psychosis, major depression, bipolar disorder, alcohol or substance abuse.
Other
- Participation in another interventional study
- Comorbidity causing disability interfering with intervention such as pain or discomfort or life expectancy less than 1 year
Who the study is looking for
- Diagnosis of Alzheimer's disease or mild cognitive impairment
- Must have study partner
- English speaking
- No verbal impairment
- Community-dwelling
- Must have webcam or smart phone
Age in the registry: 55 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Alzheimer's Disease Research Center, Icahn School of Medicine at Mount Sinai Coordinator of this site? Confirm its status | New York | United States | Unknown status |
| Louis Armstrong Center for Music and Medicine, Mount Sinai Beth Israel Coordinator of this site? Confirm its status | New York | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.